Unknown

Dataset Information

0

Preferential siRNA delivery to injured kidneys for combination treatment of acute kidney injury.


ABSTRACT: Acute kidney injury (AKI) is characterized by a sudden loss of renal function and is associated with high morbidity and mortality. Tumor suppressor p53 and chemokine receptor CXCR4 were both implicated in the AKI pathology. Here, we report on the development and evaluation of polymeric CXCR4 antagonist (PCX) siRNA carrier for selective delivery to injured kidneys in AKI. Our results show that PCX/siRNA nanoparticles (polyplexes) provide protection against cisplatin injury to tubule cells in vitro when both CXCR4 and p53 are inhibited. The polyplexes selectively accumulate and are retained in the injured kidneys in cisplatin and bilateral ischemia reperfusion injury models of AKI. Treating AKI with the combined CXCR4 inhibition and p53 gene silencing with the PCX/sip53 polyplexes improves kidney function and decreases renal damage. Overall, our results suggest that the PCX/sip53 polyplexes have a significant potential to enhance renal accumulation in AKI and deliver therapeutic siRNA.

SUBMITTER: Tang W 

PROVIDER: S-EPMC8776616 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Preferential siRNA delivery to injured kidneys for combination treatment of acute kidney injury.

Tang Weimin W   Chen Yi Y   Jang Hee-Seong HS   Hang Yu Y   Jogdeo Chinmay M CM   Li Jing J   Ding Ling L   Zhang Chuhan C   Yu Ao A   Yu Fei F   Foster Kirk W KW   Padanilam Babu J BJ   Oupický David D  

Journal of controlled release : official journal of the Controlled Release Society 20211123


Acute kidney injury (AKI) is characterized by a sudden loss of renal function and is associated with high morbidity and mortality. Tumor suppressor p53 and chemokine receptor CXCR4 were both implicated in the AKI pathology. Here, we report on the development and evaluation of polymeric CXCR4 antagonist (PCX) siRNA carrier for selective delivery to injured kidneys in AKI. Our results show that PCX/siRNA nanoparticles (polyplexes) provide protection against cisplatin injury to tubule cells in vitr  ...[more]

Similar Datasets

| S-EPMC9133205 | biostudies-literature
| S-EPMC6708481 | biostudies-literature
| S-EPMC9026119 | biostudies-literature
| S-EPMC6258029 | biostudies-literature
| S-EPMC7073538 | biostudies-literature
2024-07-08 | GSE271279 | GEO
| S-EPMC10278705 | biostudies-literature
2025-07-09 | GSE283859 | GEO
2015-05-22 | E-GEOD-61739 | biostudies-arrayexpress
2024-07-30 | GSE252111 | GEO